Taking a GLP-1 After 65

I want to be clear at the outset that this is not an argument against treating older adults. The benefits are real — SELECT showed cardiovascular event reduction with semaglutide in people with overweight or obesity and established cardiovascular disease, and the average age in that trial was in the sixties. Obstructive sleep apnea, knee osteoarthritis and type 2 diabetes all improve with weight loss, and all of them limit life considerably at this age.

It is an argument that the plan has to be different, because the thing that goes wrong is different.

The risk that actually matters

Muscle mass declines with age from roughly the fourth decade, accelerating after 60. That is sarcopenia, and it is the mechanism behind most loss of independence in later life — not a disease people are diagnosed with so much as a slope everyone is on.

Weight loss of any kind takes lean tissue alongside fat. Body-composition data from these trials show a meaningful share of loss coming from lean mass.

Those two things add together. An 72-year-old who loses 18% of their body weight over a year, with no attention to protein or resistance training, can arrive at a lower weight with better blood pressure, better glucose, better lipids — and less capacity to rise from a chair, climb stairs, or catch themselves in a stumble.

That is not a hypothetical. It is the pattern I most want to avoid, and it is entirely avoidable.

The consequence chain matters: less muscle means worse balance and slower reactions, which means falls; lower bone density means a fall is more likely to break something; and a hip fracture at 78 is a life-changing event with a mortality attached to it.

What the plan needs

Protein at the top of the range, or above. The general weight-loss target is 1.2–1.6 g per kg of body weight per day. Older muscle is less responsive to a given dose of protein — anabolic resistance — so geriatric nutrition guidance commonly argues for the upper end or beyond. Spread it across meals at 25–30 g or more per sitting rather than loading dinner.

On a suppressed appetite that is genuinely difficult, which is why a shake stops being optional. What to actually eat covers the practical structure, and the protein powder rankings the products.

Resistance training, twice a week, from week one. Not walking — walking is excellent and it is not the same stimulus. Load is what preserves muscle, and it works at every age studied. Villareal’s 2017 trial in dieting older adults found the combination of aerobic and resistance exercise preserved function best. If you are starting from a low base, this is a referral to a physiotherapist or a supervised programme, not a gym membership and hope.

Bone taken seriously. Discuss a baseline DXA scan, keep calcium at roughly 1,000–1,200 mg a day from food and supplements combined, and check vitamin D rather than guessing — the bone health rankings go through the detail.

Expect to deprescribe

This is where most of the avoidable harm in this group actually sits, and it is not the GLP-1 causing it.

Light-headedness on standing in an older adult on this drug is far more often an antihypertensive that needs reducing than anything else — and in this age group that symptom is not a nuisance, it is a fall waiting to happen. The full reasoning is in the dizziness piece.

Ask for a medication review when you start and every 3–6 months after. Do not wait for a symptom to prompt it.

Dehydration matters more here

Thirst signalling is already blunted with age before the drug quietens appetite further, and older kidneys have less reserve. Add vomiting or diarrhea and an ACE inhibitor, and acute kidney injury becomes a realistic outcome rather than a labelling formality.

Practical version: a deliberate fluid target rather than waiting to feel thirsty, oral rehydration sachets in the cupboard before they are needed, and a low threshold for phoning about a sick day — the reasoning is in the electrolytes piece.

What to monitor

• Function, not just weight. Grip strength, chair-stand time, walking speed. If those are deteriorating, the plan is wrong regardless of what the scale says.
• Weight loss rate. Faster is not better here. A slower titration and a slower loss protects muscle and bone.
• Kidney function and electrolytes, particularly after any illness.
• Vitamin B12, especially alongside metformin, and ferritin — reading your own labs covers what to ask for.
• Falls. Any fall is a reason to review the whole medication list.

The frailty question

The honest complication is that the people most likely to benefit metabolically and the people most vulnerable to losing function overlap heavily.

For someone at 75 who is robust, active, and carrying weight that is damaging their knees and their arteries, this is often a good treatment with a clear plan attached. For someone who is already frail, already losing weight unintentionally, or already struggling with stairs, the calculation is different and the answer is frequently no — or a much lower target with much closer supervision.

That distinction is about function and frailty, not about age or BMI, and it is worth asking your clinician to make it explicitly rather than leaving it implied.

What I would ask for

If I were 68 and starting this, I would want four things agreed at the outset: a slower titration than the schedule suggests, a protein target written down, a resistance-training referral rather than an instruction to exercise, and a scheduled medication review at 3 and 6 months. None of those are unusual requests, and asking for them at the start is considerably easier than reconstructing lost muscle at month twelve.